Peer Review reports
From: Transparency and reporting characteristics of COVID-19 randomized controlled trials
| Original Submission | ||
|---|---|---|
| 19 Feb 2022 | Submitted | Original manuscript |
| 19 Mar 2022 | Reviewed | Reviewer Report |
| 25 Mar 2022 | Reviewed | Reviewer Report - Ross Mounce |
| 31 Mar 2022 | Reviewed | Reviewer Report |
| 3 Apr 2022 | Reviewed | Reviewer Report |
| 5 Apr 2022 | Reviewed | Reviewer Report |
| 23 May 2022 | Author responded | Author comments - Philipp Kapp |
| Resubmission - Version 2 | ||
| 23 May 2022 | Submitted | Manuscript version 2 |
| 21 Jul 2022 | Author responded | Author comments - Philipp Kapp |
| Resubmission - Version 3 | ||
| 21 Jul 2022 | Submitted | Manuscript version 3 |
| 10 Sep 2022 | Author responded | Author comments - Philipp Kapp |
| Resubmission - Version 4 | ||
| 10 Sep 2022 | Submitted | Manuscript version 4 |
| Publishing | ||
| 13 Sep 2022 | Editorially accepted | |
| 26 Sep 2022 | Article published | 10.1186/s12916-022-02567-y |
You can find further information about peer review here.